CLINICAGENO LIMITED

Their core work

Clinicageno is a UK-based SME specializing in clinical genomics, diagnostics, and health data management. Their work spans point-of-care diagnostic device development — particularly lab-on-a-chip platforms for detecting oral and respiratory infections — and large-scale health data federation across national cohorts. They contribute genomics and data expertise to multi-partner consortia, bridging the gap between laboratory diagnostics and population-level health data infrastructure.

What they specialise in

How they've shifted over time

Clinicageno's early H2020 work (2015-2019) was rooted in applied diagnostics — developing physical devices for point-of-care infection detection (DIAGORAS) and contributing to epigenetics research in cancer (EpiPredict). Their most recent project (CINECA, 2019-2023) marks a clear pivot toward health data infrastructure, focusing on cohort federation, biobanks, and FAIR data principles at continental scale. This shift suggests the company is moving from hardware-oriented diagnostics toward data-driven personalised medicine platforms.

Clinicageno is transitioning from physical diagnostics toward digital health data infrastructure, positioning itself at the intersection of genomics and large-scale cohort data management.

How they like to work

Clinicageno operates exclusively as a consortium participant, never leading projects. With 40 unique partners across just 3 projects and 15 countries represented, they join large, diverse consortia — suggesting they are recruited for specific technical contributions rather than project management. This pattern is typical of specialist SMEs that bring niche capabilities to broader research efforts.

Despite only 3 projects, Clinicageno has collaborated with 40 unique partners across 15 countries, indicating participation in large pan-European consortia with significant geographic diversity. Their reach extends beyond Europe through CINECA's inclusion of Canadian and African partners.

What sets them apart

Clinicageno combines hands-on diagnostics expertise (microfluidics, lab-on-a-chip) with health data management capabilities (cohort federation, FAIR, biobanks) — an unusual dual competency for a small company. For consortium builders, this means a single SME partner that can contribute to both the technology development and data integration work packages. Their company name and project portfolio suggest deep roots in clinical genomics applied to practical healthcare settings.

Highlights from their portfolio

• DIAGORAS
  Largest funding (EUR 436K) and most technically specific — developing multiplexed point-of-care diagnostics for oral and respiratory infections with antibiotic resistance identification.
• CINECA
  Continental-scale health data infrastructure project spanning Europe, Canada, and Africa — demonstrates Clinicageno's transition into large-scale data federation and genomics.